XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 11,720,085 $ 7,809,487
Contract and grants receivable 998,609 926,251
Prepaid expenses 420,963 263,254
Income tax receivable 416,810
Total current assets 13,139,657 9,415,802
Security deposit 22,734 22,734
Office furniture and equipment, net 25,993 37,163
Deferred issuance costs 47,352
Intangible assets, net 53,653 73,952
Total assets 13,289,389 9,549,651
Current liabilities:    
Accounts payable 1,713,632 1,753,614
Accrued expenses 1,984,407 1,143,306
Deferred revenue 259,862
Accrued compensation 63,019 333,019
Total current liabilities 4,020,920 3,229,939
Commitments and contingencies
Shareholders' equity:    
Preferred stock, 350,000 shares authorized; none issued or outstanding
Common stock, $.001 par value; 50,000,000 and 25,000,000 shares authorized at September 30, 2018 and December 31, 2017, respectively; 17,682,839 shares and 8,730,640 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively 17,683 8,731
Additional paid-in capital 172,317,754 163,581,026
Accumulated other comprehensive loss (1,767)
Accumulated deficit (163,065,201) (157,270,045)
Total shareholders' equity 9,268,469 6,319,712
Total liabilities and shareholders' equity $ 13,289,389 $ 9,549,651